The catalogue

Peptide evidence database

The world's largest consumer peptide reference. Human studies, real prices, and a full longevity toolkit in one place. 453 compounds. 1,043 human studies.

72 have no study of that compound in people yet. 222 peptides and blends show first.

Sorted by how many people were measured, not by a match score. Strong means at least two finished studies in people, with at least a thousand people who took it. The word is a count, not a rating of whether something works. Compounds are not ranked against each other. What people report is counted on its own and never added into the band.

Most studied By use By category BPC-157 dosage Semaglutide dosage

Plate 02

Evidence catalogue

Drawers into one record

453

Compounds

1,043

Studies in people

No human study

The cards show names people search for. Each band is counted from the record. It is not a score against another compound.

How the band is counted

Compounds: 453
Studies in people: 1,043
No human study: 72
Peptides open first: 222

A molecule nobody can patent has few studies in people, because nobody will pay for the study. How we count.

Most studied in people

Peptides and blends with the most evidence in people. They are sorted by evidence band, then by how many studies in people are cited. The band counts what has been tested in people. It does not say a compound works. Compounds are not ranked against each other.

Browse by what they are used for

Goals that already have a page on this site. A compound shows up when its research areas match that goal. These cards are the first ones listed for the goal, with featured names first. The goal page lists every match and what was measured.